Text Size

A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study

Leonardi A., Doan S., Amrane M., Ismail D., Montero J., Németh J., Aragona P., Bremond-Gignac D., VEKTIS Study Group

  • 2019
  • Ophthalmology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy; Department of Ophthalmology, Bichat Hospital and Foundation A. de Rothschild, Paris, France; Global Research and Development, Santen SAS, Evry, France; Clinica Cartuja Vision, Ophthalmological Center, Universidad de Sevilla, Sevilla, Spain; Department of Ophthalmology, Semmelweis University, Budapest, Hungary; Department of Biomedical Science, University of Messina, Messina, Italy; University Hospital Necker Enfants Malades, APHP, and Rare Eye Disease Center OPHTARA, CNRS Unit FR3636, Paris Descartes University, Paris, France

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P,  Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022